Rigrodsky Regulation, P.A. Announces Investigation of Obalon Therapeutics, Inc. Merger

Push launch information from World Newswire. The AP information staff was not concerned in its creation.

Push release information from World Newswire. The AP news staff members was not included in its creation.

January 25, 2021 GMT

WILMINGTON, Del., Jan. 25, 2021 (World NEWSWIRE) — Rigrodsky Law, P.A. announces that it is investigating Obalon Therapeutics, Inc. (“Obalon”) (NASDAQ GS: OBLN ) about probable breaches of fiduciary obligations and other violations of regulation relevant to Obalon’s arrangement to merge with ReShape Lifesciences, Inc.

To understand additional about this investigation and your legal rights, pay a visit to: https://www.rl-authorized.com/situations-obalon-therapeutics-inc.

You might also speak to Seth D. Rigrodsky or Gina M. Serra cost and obligation no cost at (888) 969-4242 or [email protected].

Rigrodsky Legislation, P.A., with workplaces in Delaware and New York, has recovered hundreds of thousands and thousands of bucks on behalf of traders and realized considerable corporate governance reforms in securities fraudand company classactions nationwide.

Lawyer advertising and marketing.  Prior benefits do not ensure a related final result.


Rigrodsky Legislation, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free of charge)
(302) 295-5310
Fax: (302) 654-7530
[email protected]